Gilead Sciences, Inc. (GILD) Reaches $74.40 Formed H&S; Menta Capital Decreased Southwest Gas Holdings (SWX) Stake

Gilead Sciences, Inc. (GILD) formed H&S with $69.19 target or 7.00% below today’s $74.40 share price. Gilead Sciences, Inc. (GILD) has $97.19B valuation. The stock decreased 0.16% or $0.12 during the last trading session, reaching $74.4. About 5.86 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 9, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Menta Capital Llc decreased Southwest Gas Holdings Inc (SWX) stake by 23.88% reported in 2017Q3 SEC filing. Menta Capital Llc sold 7,000 shares as Southwest Gas Holdings Inc (SWX)’s stock declined 6.90%. The Menta Capital Llc holds 22,316 shares with $1.73M value, down from 29,316 last quarter. Southwest Gas Holdings Inc now has $3.78B valuation. The stock increased 0.56% or $0.44 during the last trading session, reaching $79.28. About 153,248 shares traded. Southwest Gas Holdings, Inc. (NYSE:SWX) has risen 14.20% since January 9, 2017 and is uptrending. It has underperformed by 2.50% the S&P500.

Among 7 analysts covering Southwest Gas Corporation (NYSE:SWX), 1 have Buy rating, 0 Sell and 6 Hold. Therefore 14% are positive. Southwest Gas Corporation had 21 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, October 13 by Jefferies. The stock has “Hold” rating by Argus Research on Tuesday, May 31. Jefferies downgraded the shares of SWX in report on Thursday, January 12 to “Underperform” rating. The rating was maintained by Jefferies on Monday, October 16 with “Hold”. The firm has “Buy” rating given on Tuesday, December 19 by UBS. The stock of Southwest Gas Holdings, Inc. (NYSE:SWX) has “Hold” rating given on Thursday, October 8 by Jefferies. The stock of Southwest Gas Holdings, Inc. (NYSE:SWX) earned “Hold” rating by Zacks on Tuesday, September 1. UBS maintained Southwest Gas Holdings, Inc. (NYSE:SWX) on Wednesday, November 8 with “Neutral” rating. Citigroup maintained Southwest Gas Holdings, Inc. (NYSE:SWX) on Monday, November 20 with “Neutral” rating. Jefferies maintained it with “Hold” rating and $72.0 target in Wednesday, December 20 report.

Investors sentiment decreased to 1.09 in Q3 2017. Its down 0.33, from 1.42 in 2017Q2. It dropped, as 27 investors sold SWX shares while 68 reduced holdings. 24 funds opened positions while 80 raised stakes. 36.72 million shares or 2.58% more from 35.80 million shares in 2017Q2 were reported. Employees Retirement Association Of Colorado reported 8,194 shares. Eulav Asset Mgmt accumulated 41,600 shares. Texas Permanent School Fund has invested 0.03% of its portfolio in Southwest Gas Holdings, Inc. (NYSE:SWX). 42,907 are owned by First Trust Advisors Limited Partnership. Mitsubishi Ufj Trust reported 0% of its portfolio in Southwest Gas Holdings, Inc. (NYSE:SWX). Ing Groep Nv invested in 5,828 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt reported 0.01% of its portfolio in Southwest Gas Holdings, Inc. (NYSE:SWX). Vanguard Group Inc owns 0.02% invested in Southwest Gas Holdings, Inc. (NYSE:SWX) for 4.44 million shares. Credit Suisse Ag holds 0.01% in Southwest Gas Holdings, Inc. (NYSE:SWX) or 80,479 shares. Td Asset Management, Ontario – Canada-based fund reported 21,770 shares. 1St Source Commercial Bank has 3,850 shares. State Of Tennessee Treasury Department holds 30,000 shares or 0.01% of its portfolio. Capstone Inv Advsrs Ltd Liability Corp holds 0.03% in Southwest Gas Holdings, Inc. (NYSE:SWX) or 11,095 shares. Ubs Asset Mgmt Americas Incorporated accumulated 0% or 28,718 shares. Millennium Management Ltd Liability Company holds 445,883 shares.

Menta Capital Llc increased Scansource Inc (NASDAQ:SCSC) stake by 8,499 shares to 28,407 valued at $1.24M in 2017Q3. It also upped Csra Inc stake by 30,424 shares and now owns 41,874 shares. Veeva Sys Inc (NYSE:VEEV) was raised too.

Analysts await Southwest Gas Holdings, Inc. (NYSE:SWX) to report earnings on February, 26. They expect $1.48 EPS, up 8.03% or $0.11 from last year’s $1.37 per share. SWX’s profit will be $70.64M for 13.39 P/E if the $1.48 EPS becomes a reality. After $0.21 actual EPS reported by Southwest Gas Holdings, Inc. for the previous quarter, Wall Street now forecasts 604.76% EPS growth.

Since August 1, 2017, it had 0 insider buys, and 11 sales for $41.13 million activity. $5.56M worth of stock was sold by MARTIN JOHN C on Tuesday, August 1. 15,000 shares valued at $1.11 million were sold by Alton Gregg H on Tuesday, January 2. Shares for $4.99 million were sold by Meyers James R. Washington Robin L sold 51,820 shares worth $4.40M.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold Gilead Sciences, Inc. shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Westend Advsr Ltd Co reported 701,463 shares or 4.99% of all its holdings. State Board Of Administration Of Florida Retirement System has 0.41% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.88 million shares. Rhumbline Advisers reported 2.32 million shares. Palladium Ptnrs Ltd Company, Virginia-based fund reported 6,660 shares. Dupont Mngmt Corporation stated it has 255,085 shares or 0.47% of all its holdings. Brighton Jones Limited Company accumulated 3,468 shares. Shamrock Asset Mgmt Limited Co reported 7,245 shares. Intact Invest Management Incorporated reported 4,100 shares. The Ohio-based Cleararc has invested 0.79% in Gilead Sciences, Inc. (NASDAQ:GILD). Citigroup owns 1.36 million shares or 0.09% of their US portfolio. Mondrian Prns Ltd invested in 772,020 shares. Convergence Prns invested 1.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Wagner Bowman Mgmt has 0.08% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Mitsubishi Ufj Tru And Banking stated it has 0.41% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Robeco Institutional Asset Management Bv holds 0.23% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 467,886 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences has $137 highest and $7200 lowest target. $97.04’s average target is 30.43% above currents $74.4 stock price. Gilead Sciences had 111 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Mkt Perform” rating by Leerink Swann given on Tuesday, September 27. The stock has “Buy” rating by Vetr on Monday, August 17. Citigroup downgraded the shares of GILD in report on Wednesday, February 8 to “Neutral” rating. BMO Capital Markets maintained the shares of GILD in report on Friday, October 27 with “Outperform” rating. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, August 31. Jefferies has “Hold” rating and $91 target. On Monday, October 16 the stock rating was maintained by Robert W. Baird with “Buy”. The company was maintained on Wednesday, November 8 by Mizuho. The firm has “Outperform” rating by BMO Capital Markets given on Wednesday, November 2. As per Friday, December 18, the company rating was initiated by Atlantic Securities. The rating was maintained by William Blair with “Buy” on Wednesday, June 14.